Loading...
XSHE
002772
Market cap696mUSD
Jul 10, Last price  
12.72CNY
1D
0.95%
1Q
-26.73%
Jan 2017
-38.16%
IPO
26.72%
Name

Tianshui Zhongxing Bio-technology Co Ltd

Chart & Performance

D1W1MN
XSHE:002772 chart
P/E
14.23
P/S
2.27
EPS
0.89
Div Yield, %
2.38%
Shrs. gr., 5y
-0.87%
Rev. gr., 5y
6.16%
Revenues
2.10b
+8.43%
131,314,967190,401,695263,940,604383,497,278479,520,219585,018,459739,792,782926,432,0561,155,832,4601,483,178,4911,556,146,7251,970,274,4121,970,274,4121,931,077,6581,935,227,3602,098,363,191
Net income
335m
+161.63%
43,576,05763,991,71554,750,39790,880,530114,381,359158,510,286142,273,056111,939,03168,403,842188,959,29254,968,006158,351,860158,351,865159,581,340128,029,455334,963,548
CFO
504m
+1.82%
93,012,21994,555,57593,028,601170,310,081209,431,109233,392,235207,336,130231,792,554359,149,932389,318,7970493,702,411524,502,689494,517,996503,517,775
Dividend
May 19, 20250.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tianshui Zhongxing Bio-technology Co.,Ltd. is a Chinese enterprise dedicated to the research, development, cultivation, and distribution of edible fungi throughout the country. Its product line features various mushroom offerings, marketed under prominent brands such as Xi Huang, Nüwa, and Zhongxing. The company, which established its operations in 2005 and is headquartered in Tianshui, China, officially adopted its current name, Tianshui Zhongxing Bio-technology Co.,Ltd., in March 2012, having previously been known as Tianshui Zhongxing Bio-technology Ltd.
IPO date
Jun 26, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT